Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
43.8M
-
Number of holders
-
91
-
Total shares
-
33M
-
Shares change
-
-13.1K
-
Total reported value, excl. options
-
$176M
-
Value change
-
+$30K
-
Number of buys
-
36
-
Number of sells
-
-37
-
Price
-
$5.35
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2023
89 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q4 2023.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
of 43.8M outstanding shares and own 75.23% of the company stock.
Largest 10 shareholders include B. Riley Asset Management, LLC (2.94M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (2.92M shares), BlackRock Inc. (2.91M shares), Harvey Partners, LLC (2.56M shares), AMH Equity Ltd (2.16M shares), VANGUARD GROUP INC (2.1M shares), DIMENSIONAL FUND ADVISORS LP (1.93M shares), Granahan Investment Management, LLC (1.84M shares), ROYCE & ASSOCIATES LP (1.45M shares), and BOOTHBAY FUND MANAGEMENT, LLC (1.36M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.